FDA Approves Abbott's Novel Dissolvable Stent Therapy for Peripheral Artery Disease
HCPLive
APRIL 29, 2024
Abbott's Esprit BTK System was shown to significantly reduce risk of ischemic events in patients with PAD versus angioplasty over 1 year.
Angioplasty Stent Stents 
Comparison of Noncompliant Balloon With Drug-Coating Balloon Angioplasties for Side Branch After Provisional Stenting for Patients With True Coronary Bifurcation Lesions
American College of Cardiology
OCTOBER 28, 2024
The goal of the DCB-BIF trial was to assess the efficacy of drug-coated balloon (DCB) angioplasty of residual side branch stenosis in coronary bifurcation lesions treated with a provisional stenting strategy.
Angioplasty 
55
55 
Resorbable stent vs. angioplasty safety outcomes: 5 study notes
Becker's Hospital Review - Cardiology
NOVEMBER 7, 2024
A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.
Stents 52
52 
Drug-Coated Balloon Angioplasty With Rescue Stenting Versus Intended Stenting for the Treatment of Patients With de Novo Coronary Artery Lesions
American College of Cardiology
SEPTEMBER 2, 2024
The goal of the REC-CAGEFREE I trial was to assess the safety and efficacy of a paclitaxel-coated balloon (DCB) compared to drug-eluting stent (DES) implantation among patients with coronary in-stent restenosis.
Stents 49
49 
Drug-Coated Balloons for the Treatment of CAD
JAMA Cardiology
DECEMBER 22, 2024
This narrative review discusses drug-coated balloon angioplasty as an alternative to drug-eluting stent for percutaneous coronary intervention in patients with in-stent restenosis and de novo coronary artery disease.
Stent‐in‐Stent Intervention for Pulmonary Vein in Stent Restenosis: A Long‐Term Follow‐Up Case Report
Journal of Cardiovascular Electrophysiology
NOVEMBER 20, 2024
Balloon angioplasty seems to be the widely preferred treatment of choice. The stenosis was treated with a stent. years later he presented with an in-stent restenosis that was successfully treated with a stent-in-stent strategy. The stenosis was treated with a stent.
Stents 40
40 
Medtronic Releases Atherectomy Studies at VIVA 2024
DAIC
NOVEMBER 8, 2024
In the DA+DCB arm, there was a trend toward higher stent-free patency through 12 months (79.1% versus 68.1%, · P=0.09) and a significantly lower provisional stenting rate (9.5% among 6 randomized controlled trials (RCTs) (172 patients), comparing favorably to published meta-analysis rates for uncoated balloon angioplasty (47.4%
Stents 52
52 
Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon
DAIC
MARCH 1, 2024
Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. vs. 28.7%; P=0.006). vs. 28.7%; P=0.006).
Stents 105
105 
ECLIPSE: Orbital Atherectomy vs. Conventional Balloon Angioplasty Prior to DES Implantation
American College of Cardiology
OCTOBER 29, 2024
The routine use of orbital atherectomy did not improve minimal stent area (MSA) or reduce target vessel failure (TVF) at one year compared with conventional balloon angioplasty prior to implantation of a drug-eluting stent (DES) in severely calcified coronary lesions.
Angioplasty 52
52 
Abstract WMP88: Intraarterial Tirofiban Through Deployed Stent-Retriever Bailout: A Potential Alternative to Angioplasty and Stenting
Stroke Journal
FEBRUARY 1, 2024
Background:In stroke patients undergoing EVT, angioplasty and stenting (A&S) has been described as a bailout technique when thrombectomy fails or intracranial stenosis is suspected. The stent-retriever was re-sheathed into the microcatheter before retrieval. Further prospective data is warranted.
Stents 40
40 
REC-CAGEFREE I: DCB Angioplasty With Rescue Stenting vs. Intended DES in Patients With de novo Noncomplex Coronary Artery Lesions
American College of Cardiology
SEPTEMBER 2, 2024
A strategy of drug-coated balloon (DCB) angioplasty with rescue stenting did not achieve noninferiority compared with intended drug-eluting stent (DES) deployment for patients with de novo, noncomplex coronary artery lesions, according to finding from the REC-CAGEFREE I trial presented at ESC Congress 2024 in London and simultaneously published in (..)
Angioplasty 40
40 
What is Coronary Artery Stenting ?
Know Your Heart
FEBRUARY 20, 2019
Coronary Artery Stents What are coronary artery stents? A stent is a tiny device made of surgical stainless steel that is placed inside an artery to hold it open and allow blood to flow through the blood vessel. When are coronary stents used? Coronary stents are used as a routine part of most angioplasty procedures.
Stents 40
40 
Trial finds drug-coated balloon angioplasty less effective than second generation drug-eluting stents
Medical Xpress - Cardiology
SEPTEMBER 2, 2024
Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing percutaneous coronary intervention (PCI).
Stents 45
45 
Abstract 044: Single?Step Intracranial Angioplasty followed by Atlas Stent Deployment Through Mini Trek Rx Balloon
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Herein, we describe a single‐step approach to deploy Neuroform Atlas stent (Stryker Neurovascular, Fremont, CA) which is a hybrid laser‐cut, nitinol self‐expanding stent without the need for ELW or lesion re‐access using MINI TREK RX (Abbott Vascular, Inc., There was no restriction on time from last known well (TLKW) to MT.
Angioplasty 40
40 
Abstract TP248: Factors associated with Silent Brain Infarcts after the Middle Cerebral Artery Stenting or Balloon Angioplasty
Stroke Journal
JANUARY 30, 2025
The objective of our study is to identify factors associated with SBIs following middle cerebral artery (MCA) stenting or balloon angioplasty.Methods:We retrospectively reviewed patients who underwent MCA stenting or balloon angioplasty, including those with symptomatic, atherosclerotic MCA stenosis of 50%.
Angioplasty 40
40 
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Journal of Cardiothoracic Surgery
DECEMBER 18, 2024
This study aimed to analyze the safety and mid-term outcomes of a hybrid treatment method combining rotational atherectomy (RA) with drug-coated balloon (DCB) angioplasty in patients with femoropopliteal arter.
Angioplasty 52
52 
Abstract 132: Angioplasty and Stenting for Symptomatic Vertebral Artery Atherosclerotic Disease: A Systematic Review and Meta?Analysis
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
IntroductionVertebral artery stenting represents a viable option in treating symptomatic vertebral artery atherosclerotic stenosis. We included articles reporting patients > 18 years old with symptomatic extracranial vertebral artery stenoses due to atherosclerosis treated with stenting (with or without angioplasty).
Angioplasty 40
40 
Abstract WMP94: Trends in Co-morbidities and Mortality in Rescue Stenting and Elective Stenting for Intracranial Atherosclerotic Disease: National Inpatient Sample Data Analysis
Stroke Journal
JANUARY 30, 2025
Introduction:Medical therapy and endovascular therapy for intracranial atherosclerotic disease (ICAD) have evolved over the past two decades with improved medical therapy benchmarks, and improved techniques and patient selection for stenting.
Stents 40
40 
Submaximal Angioplasty for Severe Intracranial Atherosclerotic Stenosis: Benefit of Revascularization at Last
Stroke Journal
MARCH 23, 2025
The longstanding benefits of percutaneous angioplasty and stenting in coronary artery disease, where atherosclerosis is the overarching cause in nearly all cases, provided a compelling rationale for exploring similar interventions in intracranial atherosclerotic stenosis.
Angioplasty 40
40 Abstract WP179: Clinical Outcomes in Acute Stroke in Patients Undergoing Emergency Intracranial Stenting Receiving IV Thrombolysis
Stroke Journal
FEBRUARY 1, 2024
In cases of stent-retriever thrombectomy failure, rescue stent angioplasty might be the sole option for achieving permanent recanalization. Among patients who underwent emergency intracranial stenting, 66 (30.6%) received intravenous thrombolytic treatment. 10.43, p=0.0325).Conclusions:The 10.43, p=0.0325).Conclusions:The
Stents 40
40 
Abstract 225: Rescue Stenting for Posterior Circulation Strokes
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Rescue treatment with stenting, balloon angioplasty, and/or intraarterial thrombolysis or antiplatelets are often required to treat the underlying stenosis. 4 Recent literature has reported clinical benefits associated with rescue stenting in the setting of ICAD‐related MT‐refractory strokes.5
Stents 40
40 Orbital atherectomy no better than balloon angioplasty
Medical Xpress - Cardiology
NOVEMBER 4, 2024
27 to 30 in Washington, D.C.
Angioplasty 40
40 
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis
American College of Cardiology
MARCH 20, 2024
The goal of the AGENT IDE trial was to assess the safety and efficacy of a paclitaxel-coated balloon (drug-coated balloon; DCB) to conventional balloon angioplasty among patients with coronary in-stent restenosis (ISR).
Stents 45
45 
Devices Flop for Severe PAD; CPR on LVAD Patients; Cancer Drugs for Heart Disease?
Med Page Today
APRIL 30, 2024
(MedPage Today) -- For patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia, drug-eluting stents and drug-coated balloons did not improve amputation-free survival compared with balloon angioplasty alone in the BASIL.
Abstract DP36: Efficacy of Endovascular Treatment for Idiopathic Intracranial Hypertension：Cerebral Venous Sinus Stenosis Treated by Stenting
Stroke Journal
JANUARY 30, 2025
All patients had headache, and funduscopic examination demonstrated papilledema for all patients. All patients had headache, and funduscopic examination demonstrated papilledema for all patients. All patients had headache, and funduscopic examination demonstrated papilledema for all patients.
Stents 40
40 
Abstract 084: Intracranial Onyx Resolute Stenting In Idiopathic Intracranial Hypertension Patient With Pre?existing Nickel Allergy: Case Report
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Recent research has identified venous sinus stenosis as a cause of IIH, a common treatment of which is venous stenting and angioplasty. An adverse event of this procedure is in‐stent stenosis (ISS), due to either neointimal hyperplasia or hypersensitivity to an element in the stent.
Stents 40
40 
Meta-Analysis Comparing Drug-Coated Balloon Versus Plain Old Balloon Angioplasty for In-stent Restenosis of Coronaries
The American Journal of Cardiology
JULY 18, 2024
Publication date: Available online 18 July 2024 Source: The American Journal of Cardiology Author(s): Safia Shaikh, Mohammad Hamza, Prakash Upreti, Mohammad Akkawi, Kripa Rajak, Mobeen Zaka Haider, Nomesh Kumar, Mustafa Turkmani, Fadi Kathawa, Salman Abdul Basit, Yasemin Bahar, Sadaf Fakhra, Yasar Sattar, M Chadi Alraies
Angioplasty 52
52 
Intravascular Ultrasound Outperforms Angiography for Peripheral Artery Disease Treatment
DAIC
APRIL 11, 2024
The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. Half were randomly assigned to receive IVUS plus angiography and half received angiography alone.
Bare metal stent application to prevent limb occlusion in iliac arteries with severe tortuosity during an endovascular aneurysm repair: a cohort study
Frontiers in Cardiovascular Medicine
DECEMBER 3, 2024
A bare metal stent (BMS) may protect LGO, according to the hypothesis of this single-center retrospective analysis.MethodsAll patients undergoing elective EVAR with a bifurcated stent graft between January 2012 and June 2022 were included in this cohort study. At a mean follow-up imaging duration of 28.7 ± 23.6 months
Aneurysm 40
40 
Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation
American College of Cardiology
OCTOBER 29, 2024
The goal of the ECLIPSE trial was to evaluate orbital atherectomy prior to drug-eluting stent (DES) implantation compared with conventional percutaneous coronary intervention (PCI) without atherectomy among patients with calcified coronary lesions.
Angioplasty 52
52 
Abstract TP220: Intracranial Dotter Angioplasty Using Tenzing for Symptomatic Atherosclerotic Stenosis: Initial Experience
Stroke Journal
FEBRUARY 1, 2024
Introduction:Traditional endovascular treatment for acutely symptomatic intracranial atherosclerotic disease (ICAD) includes balloon angioplasty and stenting. Catheter mediated angioplasty (or “Dotter” angioplasty) has been previously described for extracranial carotid and peripheral arteries.
Angioplasty 40
40 Eagle’s Eye View: Quantitative Coronary Angiography vs Intervascular Ultrasound to Guide PCI, Paclitaxel-Coated Balloon Catheters, PCI vs Coronary Artery Bypass Grafting in Left Main Disease and Diabetes
American College of Cardiology
MARCH 20, 2024
He then discusses paclitaxel-coated balloon catheters vs uncoated balloon angioplasty for treating coronary in-stent restenosis. Eagle looks at the difference between quantitative coronary angiography versus intervascular ultrasound to guide PCI.
Drug-Coated Balloon Flops for De Novo Coronary Lesions
Med Page Today
SEPTEMBER 2, 2024
(MedPage Today) -- LONDON -- Drug-coated balloon (DCB) angioplasty as the initial strategy for de novo coronary artery stenoses didn't measure up to stenting from the start, the REC-CAGEFREE I randomized trial showed. DCB with rescue use of.
Angioplasty 52
52 
Abstract 231: Rescue Stenting for Failed Mechanical Thrombectomy in Acute Ischemic Stroke:An Analysis of the SVIN Registry
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Rescue strategies options, including balloon angioplasty alone, rescue stenting (RS) alone, or stent with balloon angioplasty, have shown promise in observational studies and meta‐analyses [3, 4].
Stents 40
40 
Boston Scientific AGENT Drug-Coated Balloon Lands Long-Awaited FDA Approval
CardiacWire
MARCH 2, 2024
The United States has been way behind other nations in using drug-coated balloons (DCB) to treat coronary in-stent restenosis (ISR), but that’s about to change thanks to the FDA approval of Boston Scientific’s AGENT Drug-Coated Balloon. vs 12.3%) Stent thrombosis (0.0% vs 12.3%) Stent thrombosis (0.0%
Angioplasty 59
59 
Abstract TMP94: Association of Acute Carotid Stenting With Functional Outcome Mediated by Excellent Reperfusion in Tandem Lesions: Analysis of a Multicenter Registry
Stroke Journal
FEBRUARY 1, 2024
Introduction:Current evidence suggests that acute carotid artery stenting (CAS) for cervical lesions is associated with better functional outcomes in patients with acute stroke with tandem lesions (TLs) treated with endovascular treatment (EVT).
Stents 40
40 Abstract TP191: National Trends in Rescue Therapy for Failed Thrombectomy 2009-2020
Stroke Journal
FEBRUARY 1, 2024
Introduction:For a subset of patients with acute ischemic stroke (AIS) with large vessel occlusion (LVO) mechanical thrombectomy with a stent retriever and/or aspiration is insufficient to revascularize the target artery. Rescue therapy with angioplasty alone or with stenting has been utilized.
Angioplasty 40
40 
Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte Image Guided Crossing and Re-Entry Catheter System
DAIC
APRIL 12, 2024
If a physician fails to cross a CTO, minimally invasive revascularization options such as angioplasty and stent placement cannot be performed. Hence, in the US, many CTO patients are instead sent for bypass surgery.
Technology 111
111 
Multimodality 3D image fusion with live fluoroscopy reduces radiation dose during catheterization of congenital heart defects
Frontiers in Cardiovascular Medicine
JANUARY 10, 2024
The combined and matched subgroups were pulmonary artery stenting (Stent PUL ), aorta angioplasty (Plasty AO ), pulmonary artery angioplasty (Plasty PUL ), or a combination of the latter two (Plasty). The decrease of AK BW and DAP BW in the Stent PUL and Plasty PUL subgroups was not statistically significant.
Congenital 59
59 Research progress of drug eluting balloon in arterial circulatory system
Frontiers in Cardiovascular Medicine
MARCH 19, 2024
Drug-eluting balloons, as a new type of endovascular interventional treatment option, can avoid the long-term implantation of metal stents and is a new type of angioplasty without stents, so drug-eluting balloons have better therapeutic effects in some arterial circulatory diseases and have been initially used in clinical practice.
Research 49
49 Abstract 010: Technical Approaches for Intracranial Atherosclerotic Disease Large Vessel Occlusion Strokes
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Endovascular intervention was defined as either angioplasty, stenting, or a combination of both. ConclusionWhile limited by small subgroup sample size, medical management only was associated with relatively high rates of reocclusion, while proactive angioplasty/stenting with performed best.
Angioplasty 40
40 Proximal migration of in-stent neoatherosclerosis debris following cutting balloon angioplasty leading to catastrophic no-flow phenomenon
Coronary Artery Disease Journal
JANUARY 11, 2024
No abstract available
Angioplasty 40
40 Managing SVC Syndrome in Patients with Cardiac Implantable Electronic Device Leads: Strategies and Considerations
HeartRhythm
JULY 2, 2024
The management of this problem might require a multidisciplinary approach, often involving TV lead extraction (TLE) followed by angioplasty and stenting. Data on Transvenous (TV) lead-associated superior vena cava (SVC) syndrome are limited.
Angioplasty 40
40 
Paclitaxel-Coated Balloon Versus Uncoated Balloon Angioplasty For Coronary In-Stent Restenosis: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials
The American Journal of Cardiology
SEPTEMBER 1, 2024
Publication date: Available online 31 August 2024 Source: The American Journal of Cardiology Author(s): Ahmad Al-Abdouh, Dealla Samadi, Fares Sukhon, Mohammed Mhanna, Ahmad Jabri, Laith Alhuneafat, Taqwa Alabduh, Anas Bizanti, Luai Madanat, Mohammad Alqarqaz, Timir K Paul, Amartya Kundu
Angioplasty 40
40 
Let's personalize your content